PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
ConditionNK/T-cell Lymphoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age14-70
SponsorRuijin Hospital
About this trial
This study intends to evaluate the application value of Positron Emission Tomography/Magnetic Resonance (PET/MR) in the staging and efficacy evaluation of NK/T cell lymphoma, aiming to explore a more accurate system for predicting the prognosis of patients and guiding the treatment.
Eligibility criteria
Qualifiers
Pathologically diagnosed NK/T-cell lymphoma based on the WHO classification 2016
Age from 14 to 70 years-old
ECOG 0-2 score
Patients with a life expectancy of at least 6 months
Disqualifiers
Diagnosed aggressive NK cell leukemia
Pregnant or lactating women
Liver and kidney insufficiency
Those with implanted functional electronic devices such as cardiac pacemakers
Trial design
Treatments tested in this trial
- Positron Emission Tomography/Magnetic Resonance (PET/MR)
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov